Severe pulmonary metastasis in obese and diabetic mice

International Journal of Cancer

Volumn 119, Issue 12, 2006, Pages 2760-2767

  Mori, Akinori ^a   Sakurai, Hiroaki ^a   Choo, Min Kyung ^a   Obi, Ryosuke ^a   Koizumi, Keiichi ^a   Yoshida, Chiho ^b   Shimada, Yutaka ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SC BioSciences Corporation   (Japan)

Author keywords

Leptin; Metastasis; NK cell; Obesity

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; LEPTIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; GENE; GENETIC TRANSFECTION; LUCIFERASE GENE; LUNG METASTASIS; MALE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; HYPOGLYCEMIC AGENTS; KILLER CELLS, NATURAL; LEPTIN; LUCIFERASES; LUNG; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MELANOMA, EXPERIMENTAL; MICE; MICE, OBESE; RECOMBINANT PROTEINS; THIAZOLIDINEDIONES; TIME FACTORS; TRANSFECTION;

EID: 33751555752     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22248     Document Type: Article

References (35)

1. Kopelman PG, Obesity as a medical problem. Nature 2000;404:635-43.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
3. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
4. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002;360:861-8.
5. Baillargeon J, Rose DP. Obesity, adipokines, and prostate cancer (review). Int J Oncol 2006;28:737-45.
6. Ribeiro R, Lopes C, Medeiros R. The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis 2006;9:19-24.
7. Kaur T, Zhang ZF. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev 2005;6:547-52.
8. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999;42:107-12.
9. Hirose Y, Hata K, Kuno T, Yoshida K, Sakata K, Yamada Y, Tanaka T, Reddy BS, Mori H. Enhancement of development of azoxymethane-induced colonie premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 2004;25:821-5.
10. Maehle BO, Tretli S, Thorsen T. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS 2004;112:349-57.
11. Doki Y, Murakami K, Yamaura T, Sugiyama S, Misaki T, Saiki I. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br J Cancer 1999;79:1121-6.
12. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999;1:303-10.
13. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002;99:377-82.
14. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC. Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 1996;50:1087-94.
15. Panigrahy D, Singer S, Shen LQ, Butterfield CE, Freedman DA, Chen EJ, Moses MA, Kilroy S, Duensing S, Fletcher C, Fletcher JA, Hlatky L et al. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest 2002;110:923-32.
16. Yoshizumi T, Ohta T, Ninomiya I, Terada I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Yi S, Miwa K. Thiazolidinedione, a peroxi some proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 2004;25:631-9.
17. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-3.
18. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995;96:2065-70.
19. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
20. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ, Ross RJ. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001;167:4593-9.
21. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901.
22. Tian Z, Sun R, Wei H, Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 2002;298:297-302.
23. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J Natl Cancer Inst 1980;65:929-35.
24. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982;30:107-12.
25. Thompson CI, Kreider JW, Black PL, Schmidt TJ, Margules DL. Genetically obese mice: resistance to metastasis of B16 melanoma and enhanced T-lymphocyte mitogenic responses. Science 1983;220:1183-5.
26. Black PL, Holly M, Thompson CI, Margules DL. Enhanced tumor resistance and immunocompetence in obese (ob/ob) mice. Life Sci 1983;33:715-18.
27. Simons JP, Schols AM, Campfield LA, Wouters EF, Saris WH. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci 1997;93:273-7.
28. Cederholm T, Arner P, Palmblad J. Low circulating leptin levels in protein-energy malnourished chronically ill elderly patients. J Intern Med 1997;242:377-82.
29. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
30. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Regele A, Lammer C, Peiser C, Lang RE. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996;137:1501-4.
31. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR, Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997;99:385-90.
32. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348:159-61.
33. Dovio A, Caramello V, Masera RG, Sartori ML, Saba L, Tinivella M, Prolo P, Termine A, Avagnina P, Angeli A. Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition. Int J Obes Relat Metab Disord 2004;28:894-901.
34. Gottschlich MM, Mayes T, Khoury JC, Warden GD. Significance of obesity on nutritional, immunologic, hormonal, and clinical outcome parameters in bums. J Am Diet Assoc 1993;93:1261-8.
35. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.